JG
UTHR icon

Jain Global’s United Therapeutics UTHR Stock Holding History

Jain Global’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$703K Buy
+1,298
New +$731K ﹤0.01% 1100
2025
Q4 		– Sell
-20,794
Closed -$8.72M – 1538
2025
Q3 		$8.72M Buy
+20,794
New +$6.99M 0.04% 257

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Jain Global's UTHR Position: Q2 2026 in Review

Jain Global opened a new position in United Therapeutics (UTHR) in Q2 2026: 1,298 shares worth $703K. The stake represents ﹤0.01% of the portfolio and ranks #1100 among its holdings. This is a return to the name: Jain Global previously reported a position in UTHR as recently as Q3 2025.

Jain Global first reported a position in UTHR in Q3 2025 and has held it in 2 quarters since. The position peaked at $8.72M in Q3 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Jain Global held 1,298 shares of United Therapeutics worth $703K as of Q2 2026.
  • United Therapeutics was a new Jain Global position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1100 holding.
  • Jain Global first reported a position in United Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Jain Global's United Therapeutics position peaked at $8.72M in Q3 2025.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.